In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in the Sep. 26 ...

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

Autumn is here, and once again, warnings are going up about the spread of the covid-19 virus — along with the flu and RSV, or ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...

Leaders from the Pennsylvania Departments of Health and Insurance this week encouraged all Pennsylvanians to stay up to date on their annual vaccinations to protect against flu, COVID-19, and ...

Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective ...

Health officials have raised the alarm over a drop in flu vaccine uptake after data showed 18,000 deaths associated with the ...

Figures show flu killed almost as many people as Covid over the past two winters as people are urged to get protected against ...

Fall brings cooler days and more time indoors. This makes it easier for viruses like influenza, COVID-19 and respiratory ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...

Forecasts suggest respiratory infections will be similar to last year's season. Vaccination rates will be a factor in the ...